Ana B. Pavel

A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results

Brett King, Emma Guttman‐Yassky, Elena Peeva et al. · Journal of the American Academy of Dermatology · 2021 · 184 citations · Full text

Backgroundalopecia Areata, Pharmacology, Clinical Trials +10

Phase 2a randomized clinical trial of dupilumab (anti‐IL‐4Rα) for alopecia areata patients

Emma Guttman‐Yassky, Yael Renert‐Yuval, Jennifer Bares et al. · Allergy · 2021 · 133 citations · Full text

Th2/Th1 Cytokine Imbalance Is Associated With Higher COVID-19 Risk Mortality

Ana B. Pavel, Jacob W. Glickman, James R. Michels et al. · Frontiers in Genetics · 2021 · 101 citations · Full text

Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata

Yael Renert‐Yuval, Ana B. Pavel, Ester Del Duca et al. · Allergy · 2022 · 49 citations · Full text

Vascular inflammation in moderate‐to‐severe atopic dermatitis is associated with enhanced Th2 response

A. Villani, Ana B. Pavel, Jianni Wu et al. · Allergy · 2021 · 42 citations